Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 1
作者:Victor J. Bauer、Brian J. Duffy、David Hoffman、Solomon S. Klioze、Raymond W. Kosley、Arthur R. McFadden、Lawrence L. Martin、Helen H. Ong、Harry M. Geyer
DOI:10.1021/jm00233a012
日期:1976.11
Synthesis of 1'-methyl-3-phenylspiro[isobenzofuran-1(3H),4'-piperidine] (7a, HP 365) and the demethyl analogue 9a (HP 505) was prompted by recognition of an aminoalkyl(aryl)isobenzofuran moiety common to the antidepressants talopram (Lu 3-010) and trans-10,11-dihydro-5,10-epoxy-5-[3-(methylamino)propyl]-5H-dibenzo[a,d]cyclohepten-11-ol (MK-940). Convenient laboratory synthesis of 7a was provided by
识别氨基烷基(芳基)异苯并呋喃部分可促进1'-甲基-3-苯基螺[异苯并呋喃-1(3H),4'-哌啶](7a,HP 365)和脱甲基类似物9a(HP 505)的合成抗抑郁药talopram(Lu 3-010)和trans-10,11-dihydro-5,10-epoxy-5- [3-(甲基氨基)丙基] -5H-dibenzo [a,d] cyclohepten-11-ol共有(MK-940)。通过2-溴二苯甲基甲基醚的锂化反应,然后添加1-甲基-4-哌啶酮和酸催化的环化反应,可以方便地合成7a。通过标准方法的N-脱烷基化得到9a。通过发现丁苯那嗪对前导化合物7a和9a引起的上睑明显抑制,刺激了类似物的合成。最佳的抗丁苯那嗪活性与3-苯基螺-[异苯并呋喃-1(3H),4'-哌啶]部分相关,其中氮为碱性。通过引入大的氮取代基或大于H的C-3取代基对该部分进行修饰,显着降低了抗丁苯那嗪的活性。研究